Diampa M 12.5/1000mg Tablet – Empagliflozin 12.5mg + Metformin 1000mg High-Dose Dual Therapy for Type 2 Diabetes
Diampa M 12.5/1000mg Tablet – Empagliflozin 12.5mg + Metformin 1000mg High-Dose Dual Therapy for Type 2 Diabetes
Diampa M 12.5/1000mg Tablet – Empagliflozin 12.5mg + Metformin 1000mg High-Dose Dual Therapy for Type 2 Diabetes
Description
Diampa M 12.5/1000mg Tablet – Intensive Dual Action for Patients Needing Stronger Glycemic Control
Diampa M 12.5/1000mg Tablet pairs Empagliflozin 12.5mg with a full therapeutic dose of Metformin 1000mg to provide robust, round-the-clock glucose management for adults with type 2 diabetes who require more intensive treatment. The SGLT2 inhibitor forces the kidneys to eliminate excess sugar in urine, while the higher metformin strength powerfully suppresses liver glucose production and boosts peripheral insulin sensitivity. This proven synergy delivers significant HbA1c lowering (often 1.5–2%), meaningful weight reduction, and the established cardiovascular and renal protective benefits that make this combination a preferred choice in modern diabetes guidelines.


